MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2023 International Congress

    Asymptomatic Gaucher disease presented as Parkinsonism in 61 years old patient.

    E. Basha, E. Ranxha, J. Tana (Tirana, Albania)

    Objective: Gaucher disease is an inherited disease caused by a mutation in the glucocerebrosidase gene, causing visceral, hematologic, and skeletal involvement. [1] [2] We report…
  • 2023 International Congress

    Establishing a Natural History of X-linked Dystonia Parkinsonism

    P. Acuna, ML. Supnet-Wells, N. Spencer, JK. de Guzman, M. Russo, A. Hunt, C. Stephen, C. Go, S. Carr, N. Ganza-Bautista, JB. Lagarde, S. Begalan, T. Muthaupt-Buell, G. Aldykiewicz, L. Paul, L. Ozelius, C. Bragg, B. Perry, J. Green, J. Miller, N. Sharma (Roxas City, Philippines)

    Objective: Our main objective is to establish a comprehensive, quantitative assessment of movement dysfunction and bulbar motor impairments that are sensitive and specific to disease…
  • 2023 International Congress

    White Matter Lesion Characteristics of Patients with Multiple Sclerosis and Parkinsonism

    Y. Shi, S. Gadani, K. Mills (Baltimore, USA)

    Objective: To evaluate whether patients with multiple sclerosis who develop parkinsonism have significant differences in regional lesion burden compared to multiple sclerosis patients who do…
  • 2023 International Congress

    Identification of ZYIL1, a novel NLR family pyrin domain containing 3 protein inhibitor: a potential disease modifier in Parkinson’s disorder

    A. Chatterjee (Ahmedabad, India)

    Objective: Identification and evaluation of the potential of a novel NLR family pyrin domain containing 3 (NLRP3) inflammasome inhibitor (ZYIL1) as a Parkinson’s disease (PD)…
  • 2023 International Congress

    Motor evaluation of Parkinson disease and Vascular parkinsonism using the TUG encephalog application

    L. Franken, J. Reiner, M. Mermelstein, D. Biederko, R. Djaldettti (Petah Tikva, Israel)

    Objective: We aimed to compare gait and parkinsonian features between PD patients, VP patients and PD patients with Vascular component (PDVC) using a smartphone-based motion…
  • 2023 International Congress

    Diagnostic challenges in a case of SLC6A3-related Dopamine Transporter Deficiency Syndrome

    L. Jafri, J. Martindale (Winston Salem, USA)

    Objective: We report a case presenting with symptoms of classical Dopamine Transporter Deficiency Syndrome (DTDS) with negative results on initial whole-exome sequencing (WES), but eventually…
  • 2023 International Congress

    To stimulate or not to stimulate? Bilateral subthalamic (STN) Deep Brain Stimulation (DBS) in cases of young-onset parkinsonism with mitochondrial dysfunction induced neurodegeneration.

    E. Efthymiou, B. Büchele, S. Mahendran, L. Stieglitz, C. Baumann, B. Balint (zurich, Switzerland)

    Objective: To describe two cases of young-onset parkinsonism (YOP; case 1 with mitochondrial membrane protein associated neurodegeneration (MPAN) due to a heterozygous mutation in C19orf12;…
  • 2023 International Congress

    Prodromal stage early biomarkers in Parkinson’s disease and parkinsonism in Uzbek nationality

    DT. Akramova, GS. Rakhimbaeva (Tashkent, Uzbekistan)

    Objective: Evaluation of prodromal stage biomarkers in Parkinson's disease and their role in disease progression Background: From a pathophysiological point of view, PD is characterized…
  • 2023 International Congress

    Iron deposition and volume change of deep grey matter nuclei in PARK14 by Quantitative Susceptibility Mapping

    C. Chen, X. Liu, F. Liu, Y. Sun, J. Wang (Shanghai, China)

    Objective: PLA2G6 is the causative gene for autosomal recessive Dystonia-Parkinsonism (PARK14). The aim of this study was to explore the characteristics of iron deposition within…
  • 2023 International Congress

    Effect of ADX-88178, a highly-selective mGlu4 PAM, on parkinsonism, dyskinesia and psychosis-like behaviours in the MPTP-lesioned marmoset

    I. Frouni, C. Kwan, D. Bédard, W. Kang, S. Nuara, J. Gourdon, P. Huot (Montreal, Canada)

    Objective: To investigate the effect of the metabotropic glutamate 4 (mGlu4) positive allosteric modulator (PAM) ADX-88178 on parkinsonism, dyskinesia and psychosis-like behaviours (PLBs) in the…
  • « Previous Page
  • 1
  • …
  • 40
  • 41
  • 42
  • 43
  • 44
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • #24475 (not found)
  • #24187 (not found)
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley